Top Stories Moximed’s MISHA™ Knee System Treats First Commercial Patients in United States byJosh SandbergSeptember 6, 2023
Recon Regulatory Sports Medicine Top Stories FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis byJosh SandbergApril 11, 2023
Sports Medicine Top Stories Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study byJosh SandbergSeptember 23, 2022
Financial Sports Medicine Moximed Raises $40 Million to Advance World’s First Implantable Shock Absorber for Knee Osteoarthritis byJosh SandbergAugust 16, 2022
Recon Cost Effectiveness and Economic Impact of the KineSpring® Knee Implant System in the Treatment of Knee Osteoarthritis in Spain. byJosh SandbergJanuary 22, 2016
Extremities Moximed Announces CE Mark and First Commercial Use of AtlasTM Knee System byJosh SandbergNovember 19, 2015
Extremities Financial Medical device maker Moximed raises funds for knee implant byJosh SandbergMay 12, 2015
